PYC pyc therapeutics limited

alzheimer’s breakthrough

  1. 315 Posts.
    Cambridge Chemists have pinpointed the catalytic trigger for Alzheimer's disease:

    http://www.cam.ac.uk/research/news/scientists-identify-molecular-trigger-for-alzheimers-disease

    Given that a likely therapeutic modality will be in "silencing" the protein(s) triggering the cascade to neuron death - I wonder if this presents Phylogica with an ideal platform:

    - Blood Brain Barrier transversal

    - Cell penetration

    - Protein silencing (mapping to a specific conformal shape)

    Interesting times for the Phylomer technology platform.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.39
Change
0.030(2.21%)
Mkt cap ! $810.7M
Open High Low Value Volume
$1.39 $1.39 $1.33 $103.4K 75.90K

Buyers (Bids)

No. Vol. Price($)
1 2600 $1.37
 

Sellers (Offers)

Price($) Vol. No.
$1.39 14999 1
View Market Depth
Last trade - 16.10pm 21/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.